Prevalence and clinical correlates of metabolic syndrome in nigerians living with human immunodeficiency virus/acquired immunodeficiency syndrome

Metabolic Syndrome and Related Disorders

Volumn 10, Issue 5, 2012, Pages 373-379

  Ayodele, Olugbenga Edward ^a   Akinboro, Adeolu Oludayo ^a   Akinyemi, Suliat Omolola ^b   Adepeju, Akinlawon Adetiloye ^b   Akinremi, Oluwaseun Akinsanmi ^b   Alao, Christiana Adeola ^c   Popoola, Adetoun Adedayo ^c  

^a LADOKE AKINTOLA UNIVERSITY OF TECHNOLOGY   (Nigeria)

^b Ladoke Akintola University   (Nigeria)

^c Teaching Hospital   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY HEIGHT; BODY MASS; CD4 LYMPHOCYTE COUNT; CHOLESTEROL BLOOD LEVEL; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; EDUCATIONAL STATUS; EMPLOYEE; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIP CIRCUMFERENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NIGERIA; OCCUPATION; OUTPATIENT; PENSIONER; PREVALENCE; PRIORITY JOURNAL; SELF EMPLOYMENT; SMOKING; STUDENT; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; WAIST HIP RATIO;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CROSS-SECTIONAL STUDIES; FEMALE; HIV; HIV INFECTIONS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NIGERIA; PREVALENCE; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 84872872827     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2012.0050     Document Type: Article

References (41)

1. Global Report: UNAIDS report on the global AIDS epidemic 2010. Available at www.unaids.org/globalreport/global-report.htm. Accessed on April 28, 2011.
2. The Global Burden of Disease, 2004 update. Available at www.GBD-report-2004 update-full.pdf. Accessed June 23, 2012.
3. Pallela FJ Jr, Delaney KM, Moorman AC, et al and the HIV Outpatient Study Investigators. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-860.
4. Sterne JAC, MA Hernan MA, Ledergerber B, et al. and the Swiss HIV Cohort Study. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: A prospective cohort study. Lancet 2005;366:378-384.
5. Jerico C, Knobel H, Montero M, et al. Metabolic syndrome among HIV-infected patients: Prevalence, characteristics and related factors. Diabetes Care 2005;28:144-149.
6. Mondy K, Overton ET, Grabb J, et al. Metabolic syndrome in HIV-infected patients from an urban, mid-western US outpatient population. Clin Infect Dis 2007;44:726-734.
7. Bonfanti P, Giannattasio C, Ricci E, et al. HIV and metabolic syndrome: A comparison with the general population. J Acquir Immune Defic Syndr 2007;45:426-431.
8. Cubero JM, Domingo P, Sambeat M, et al. Prevalence of metabolic syndrome among human immunodeficiency virus-infected subjects is widely influenced by the diagnostic criteria. Metab Syndr Relat Disord 2011;5:345-351.
9. Adeyemi O, Rezai K, Bahk M, et al. Metabolic syndrome in older HIV-infected patients: Data from the CORE50 cohort. AIDS Patient Care STDs 2008;22:941-945.
10. Bergersen BM, Schumacker A, Sandvik L, et al. Important differences in components of the metabolic syndrome between HIV patients with and without highly active antiretroviral therapy and healthy controls. Scand J Infect Dis 2006;38:682-689.
11. Worm SW, Friis-Moller N, Bruyand M, et al. for the DAD study group. High prevalence of the metabolic syndrome in HIV-infected patients: Impact of different definitions of the metabolic syndrome. AIDS 2010;24:427-435.
12. Samaras K, Wand H, Law M, et al. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: Associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinaemia. Diabetes Care 2007;30:113-119.
13. Gazzaruso C, Sacchi P, Garzaniti A, et al. Prevalence ofmetabolic syndrome among HIV patients. Diabetes Care 2002;25:1253-1254.
14. Palacios R, Santos J, Gonzalez M, et al. Incidence and prevalence of metabolic syndrome in a cohort of na?̈ve HIV infected patients: Prospective analysis at 48 weeks of highly active antiretroviral therapy. Int J STD AIDS 2007;18:184-187.
15. Hadigan C, Meigs JB, Corcoran C, et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis 2001;32:130-139.
16. Alencastro PR, Fuchs SC, Wolff FH, et al. Independent predictors of metabolic syndrome in HIV-infected patients. AIDS Patient Care STDs 2011;25:627-634.
17. Federal Ministry of Health, Nigeria. 2010 National HIV Seroprevalence Sentinel Survey. Available at www.HSS-2010-Report.pdf/. Accessed June 23, 2012.
18. Thompson MA, Aberg JA, Cahn P, et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA Panel. JAMA 2010;304:321-333.
19. Obesity and overweight. Available at www.who.int.media centre/factsheets/fs311/en/index.html. Accessed May 2012.
20. Chobanian AV, Bakris GL, Black HR, et al. for the National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252.
21. www.bhsoc.org/blood-pressure-list.stm/bp-monitors/bp-monitors/automatic/ stm
22. Allain CC, Poon LS, Chan CS, et al. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-475.
23. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasmawithout use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
24. Expert Panel on Detection, Evaluation, and Treatment on High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
25. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Available at www.idf.org/webdata/docs/Metac- syndrome-def.pdf/. Accessed June 23, 2012.
26. Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645.
27. Landis JR, Koch CG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
28. Oladapo OO, Salako L, Sodiq O, et al. A prevalence of cardiometabolic risk factors among a rural Yoruba southwestern Nigerian Population: A population-based survey. Cardiovasc J Afr 2010;21:26-31.
29. Adegoke OA, Adedoyin RA, Balogun MO, et al. Prevalence of metabolic syndrome in a rural community in Nigeria. Metab Syndr Relat Disord 2010;8:59-62.
30. Ulasi II, Ijoma CK, Onodugo OD. A community-based study of hypertension and cardio-metabolic syndrome in semiurban and urban rural communities in Nigeria. BMC Health Services Res 2010;10:71.
31. Sani MU, Wahab KW, Yusuf BO, et al. Modifiable cardiovascular risk factors among apparently healthy adult Nigerian population-a cross-sectional study. BMC Res Notes 2010;3:10.
32. Siminialayi IM, Emem-Chioma PC, Odia OJ. Prevalence of metabolic syndrome in urban and sub-urban Rivers state, Nigeria: International Diabetes Federation and Adult Treatment Panel III definitions. Niger Postgrad Med J 2010;17:147-153.
33. Okafor CI. The metabolic syndrome in Africa: Current trends. Indian J Endocr Metab 2012;16:56-66.
34. Yu SS, Castillo DC, Courville AB, et al. The triglyceride paradox in people of African descent. Metab Syndr Relat Disord 2012;10:77-82.
35. Despres JP, Couillard C, Gagnon J, et al. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: The Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. Arterioscler Thromb Vasc Biol 2000;20:1932-1938.
36. Florez H, Mendez A, Casanova-Romero P, et al. Increased apolipoprotein C-III levels associated with insulin resistance contribute to dyslipidaemia in normoglycaemic and diabetic subjects from a triethnic population. Atherosclerosis 2006;188: 134-141.
37. Sumner AE, Vega GL, Genovese DJ, et al. Normal triglyceride levels despite insulin resistance in African Americans: Role of lipoprotein lipase. Metabolism 2005;54:902-909.
38. Sumner AE, Zhou J, Doumatey A, et al. Low HDL-cholesterol with normal triglyceride levels is the most common lipid pattern in West Africans and African Americans with metabolic syndrome: implications for cardiovascular prevention. CVD Prev Control 2010;5:75-80.
39. Wand H, Calmy A, Carey DL, et al. on behalf of the INITIO Trial International Coordinating Committee. Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection. AIDS 2007;21:2445-2453.
40. Grinspoon SK. Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus. Am J Med 2005;118(Suppl 2):23S-28S.
41. Lee JE, Choi SY, Huh W, et al. Metabolic syndrome, C-reactive protein, chronic kidney disease in nondiabetic, nonhypertensive adults. Am J Hypertens 2007;20:1189-1194.